BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide

被引:52
作者
Qin, HY
Singh, B
机构
[1] UNIV WESTERN ONTARIO,DEPT IMMUNOL & MICROBIOL,LONDON,ON,CANADA
[2] JOHN P ROBARTS RES INST,LONDON,ON N6A 5K8,CANADA
关键词
BCG; cyclophosphamide; diabetes; CD4(+)CD45RB; GAD67;
D O I
10.1006/jaut.1997.0136
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have previously shown that immunotherapy with complete Freund's adjuvant (CFA) or BCG is highly effective in the prevention of spontaneous insulin-dependent diabetes mellitus (IDDM) and in circumventing the rejec tion of syngeneic islet grafts in diabetic NOD mice. This protection is reversed by treatment with cyclophosphamide (Cy). The present study was undertaken to determine the effect of BCG vaccination on the progression of Cy-accelerated diabetes in NOD mice and to understand the mechanism of BCG immunotherapy. The time course of Cy and BCG administration showed that the progression of Cy-induced diabetes can onlybe blocked when BCG vaccination is given within 3 days of Cy administration. Mice given BCG 3 days before (-3 days) or 7 days after Cy treatment were not protected. BCG immunization 1 day after Cy treatment almost completely prevented insulitis in the islets of Cy-treated mice. Cy treatment reduced the endogenous production of anti-GAD67 antibody, whereas BCG vaccination 1 day after Cy treatment restored the production of anti-GAD67 antibody of IgG1 isotype. The comprehensive effect of BCG vaccination on cytokine production in Cy-treated mice was to increase IL-4 production and change the IL-4/IFN-gamma ratio in both serum and supernatant of spleen cell cultures. We found that BCG-induced protection was associated with increased splenic CD4(+)CD45 RBhigh T cells. Taken together, our results indicate that BCG treatment counteracts the effect of Cy on autoimmune process in IDDM. However, BCG immunotherapy has a narrow window of up to 3 days after Cy treatment to block the progression of Cy-induced diabetes and to allow for the induction of regulatory cells which may effectively downregulate the diabetogenic cells. In summary, our results suggest that BCG vaccination prevents IDDM if given in the prediabetic state. After the induction of diabetes, disease progression can only be prevented within a narrow window of opportunity by this treatment. (C) 1997 Academic Press Limited.
引用
收藏
页码:271 / 278
页数:8
相关论文
共 26 条
[1]  
ANDERSEN P, 1995, J IMMUNOL, V154, P3359
[2]   PREVENTION OF DIABETES AND INSULITIS BY NEONATAL INTRATHYMIC ISLET ADMINISTRATION IN NOD MICE [J].
CHARLTON, B ;
TAYLOREDWARDS, C ;
TISCH, R ;
FATHMAN, CG .
JOURNAL OF AUTOIMMUNITY, 1994, 7 (05) :549-560
[3]   CYCLOPHOSPHAMIDE-INDUCED DIABETES IN NOD WEHI MICE - EVIDENCE FOR SUPPRESSION IN SPONTANEOUS AUTOIMMUNE DIABETES-MELLITUS [J].
CHARLTON, B ;
BACELJ, A ;
SLATTERY, RM ;
MANDEL, TE .
DIABETES, 1989, 38 (04) :441-447
[4]   IMMUNIZATION WITH THE LARGER ISOFORM OF MOUSE GLUTAMIC-ACID DECARBOXYLASE (GAD(67)) PREVENTS AUTOIMMUNE DIABETES IN NOD MICE [J].
ELLIOTT, JF ;
QIN, HY ;
BHATTI, S ;
SMITH, DK ;
SINGH, RK ;
DILLON, T ;
LAUZON, J ;
SINGH, B .
DIABETES, 1994, 43 (12) :1494-1499
[5]   INVERSE RELATION BETWEEN HUMORAL AND CELLULAR-IMMUNITY TO GLUTAMIC-ACID DECARBOXYLASE IN SUBJECTS AT RISK OF INSULIN-DEPENDENT DIABETES [J].
HARRISON, LC ;
HONEYMAN, MC ;
DEAIZPURUA, HJ ;
SCHMIDLI, RS ;
COLMAN, PG ;
TAIT, BD ;
CRAM, DS .
LANCET, 1993, 341 (8857) :1365-1369
[6]   POTENTIATION OF T-CELL-MEDIATED IMMUNITY BY SELECTIVE SUPPRESSION OF ANTIBODY-FORMATION WITH CYCLOPHOSPHAMIDE [J].
LAGRANGE, PH ;
MACKANESS, GB ;
MILLER, TE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1974, 139 (06) :1529-1539
[7]   LONG-TERM SURVIVAL OF SYNGENEIC ISLET GRAFTS IN BCG-TREATED DIABETIC NOD MICE CAN BE REVERSED BY CYCLOPHOSPHAMIDE [J].
LAKEY, JRT ;
SINGH, B ;
WARNOCK, GL ;
ELLIOTT, JF ;
RAJOTTE, RV .
TRANSPLANTATION, 1995, 59 (12) :1751-1753
[8]   BCG IMMUNOTHERAPY PREVENTS RECURRENCE OF DIABETES IN ISLET GRAFTS TRANSPLANTED INTO SPONTANEOUSLY DIABETIC NOD MICE [J].
LAKEY, JRT ;
SINGH, B ;
WARNOCK, GL ;
RAJOTTE, RV .
TRANSPLANTATION, 1994, 57 (08) :1213-1217
[9]  
LUGMAN M, 1991, EUR J IMMUNOL, V21, P17
[10]   MODIFYING EFFECT OF BCG ON IMMUNOLOGICAL INDUCTION OF T-CELLS [J].
MACKANESS, GB ;
LAGRANGE, PH ;
ISHIBASHI, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1974, 139 (06) :1540-1552